356 related articles for article (PubMed ID: 24035588)
1. New opportunities: harnessing induced pluripotency for discovery in diabetes and metabolism.
Teo AK; Wagers AJ; Kulkarni RN
Cell Metab; 2013 Dec; 18(6):775-91. PubMed ID: 24035588
[TBL] [Abstract][Full Text] [Related]
2. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
[TBL] [Abstract][Full Text] [Related]
3. Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model.
Jeon K; Lim H; Kim JH; Thuan NV; Park SH; Lim YM; Choi HY; Lee ER; Kim JH; Lee MS; Cho SG
Stem Cells Dev; 2012 Sep; 21(14):2642-55. PubMed ID: 22512788
[TBL] [Abstract][Full Text] [Related]
4. Human Induced Pluripotent Stem Cells in the Curative Treatment of Diabetes and Potential Impediments Ahead.
Dadheech N; James Shapiro AM
Adv Exp Med Biol; 2019; 1144():25-35. PubMed ID: 30569414
[TBL] [Abstract][Full Text] [Related]
5. Induced Pluripotent Stem Cells (iPSCs) in Developmental Toxicology.
Easley CA
Methods Mol Biol; 2019; 1965():19-34. PubMed ID: 31069666
[TBL] [Abstract][Full Text] [Related]
6. Induced Pluripotent Stem Cell-Derived Endothelial Cells in Insulin Resistance and Metabolic Syndrome.
Carcamo-Orive I; Huang NF; Quertermous T; Knowles JW
Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2038-2042. PubMed ID: 28729365
[TBL] [Abstract][Full Text] [Related]
7. Disease-specific induced pluripotent stem cells: a platform for human disease modeling and drug discovery.
Jang J; Yoo JE; Lee JA; Lee DR; Kim JY; Huh YJ; Kim DS; Park CY; Hwang DY; Kim HS; Kang HC; Kim DW
Exp Mol Med; 2012 Mar; 44(3):202-13. PubMed ID: 22179105
[TBL] [Abstract][Full Text] [Related]
8. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
[TBL] [Abstract][Full Text] [Related]
9. Transgene-free disease-specific induced pluripotent stem cells from patients with type 1 and type 2 diabetes.
Kudva YC; Ohmine S; Greder LV; Dutton JR; Armstrong A; De Lamo JG; Khan YK; Thatava T; Hasegawa M; Fusaki N; Slack JM; Ikeda Y
Stem Cells Transl Med; 2012 Jun; 1(6):451-61. PubMed ID: 23197849
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Cardiomyocyte Differentiation Potential Between Type 1 Diabetic Donor- and Nondiabetic Donor-Derived Induced Pluripotent Stem Cells.
Kikuchi C; Bienengraeber M; Canfield S; Koopmeiner A; Schäfer R; Bosnjak ZJ; Bai X
Cell Transplant; 2015; 24(12):2491-504. PubMed ID: 25562386
[TBL] [Abstract][Full Text] [Related]
11. Regenerative medicine for diabetes: differentiation of human pluripotent stem cells into functional β-cells in vitro and their proposed journey to clinical translation.
Bose B; Katikireddy KR; Shenoy PS
Vitam Horm; 2014; 95():223-48. PubMed ID: 24559920
[TBL] [Abstract][Full Text] [Related]
12. Investigating pediatric disorders with induced pluripotent stem cells.
Durbin MD; Cadar AG; Chun YW; Hong CC
Pediatr Res; 2018 Oct; 84(4):499-508. PubMed ID: 30065271
[TBL] [Abstract][Full Text] [Related]
13. Induced pluripotent stem cells in medicine and biology.
Takahashi K; Yamanaka S
Development; 2013 Jun; 140(12):2457-61. PubMed ID: 23715538
[TBL] [Abstract][Full Text] [Related]
14. Effects of vanadate on the expression of genes involved in fuel homeostasis in animal models of Type I and Type II diabetes.
Brichard SM
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):121-4. PubMed ID: 8927026
[TBL] [Abstract][Full Text] [Related]
15. Generation of pancreatic insulin-producing cells from rhesus monkey induced pluripotent stem cells.
Zhu FF; Zhang PB; Zhang DH; Sui X; Yin M; Xiang TT; Shi Y; Ding MX; Deng H
Diabetologia; 2011 Sep; 54(9):2325-36. PubMed ID: 21755313
[TBL] [Abstract][Full Text] [Related]
16. Present and future challenges of induced pluripotent stem cells.
Ohnuki M; Takahashi K
Philos Trans R Soc Lond B Biol Sci; 2015 Oct; 370(1680):20140367. PubMed ID: 26416678
[TBL] [Abstract][Full Text] [Related]
17. Lessons from iPSC research: Insights on peripheral nerve disease.
Mittal K; Schrenk-Siemens K
Neurosci Lett; 2020 Nov; 738():135358. PubMed ID: 32898616
[TBL] [Abstract][Full Text] [Related]
18. Induced Pluripotent Stem Cells and Induced Pluripotent Cancer Cells in Cancer Disease Modeling.
Zhu D; Kong CSL; Gingold JA; Zhao R; Lee DF
Adv Exp Med Biol; 2018; 1119():169-183. PubMed ID: 30069853
[TBL] [Abstract][Full Text] [Related]
19. Derivation of human induced pluripotent stem cells from patients with maturity onset diabetes of the young.
Teo AK; Windmueller R; Johansson BB; Dirice E; Njolstad PR; Tjora E; Raeder H; Kulkarni RN
J Biol Chem; 2013 Feb; 288(8):5353-6. PubMed ID: 23306198
[TBL] [Abstract][Full Text] [Related]
20. Generation of a human induced pluripotent stem cell (iPSC) line from a patient with family history of diabetes carrying a C18R mutation in the PDX1 gene.
Wang X; Chen S; Burtscher I; Sterr M; Hieronimus A; Machicao F; Staiger H; Häring HU; Lederer G; Meitinger T; Lickert H
Stem Cell Res; 2016 Sep; 17(2):292-295. PubMed ID: 27879214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
